Bethanechol

Back to search

Molecule Structure

Scientific Name

Bethanechol

Description of the Drug

Bethanechol is a muscarinic agonist used to treat postoperative and postpartum nonobstructive functional urinary retention and neurogenic atony of the bladder with retention.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01019

Brand Name(s)

Not Available

Company Owner(s)

Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Amneal Pharmaceutical, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Impax Laboratories Inc, Able Laboratories Inc, Upsher Smith Laboratories Llc, Lannett Holdings Inc, Glenwood Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Muscarinic acetylcholine receptor M2 SINGLE PROTEIN AGONIST CHEMBL211
Muscarinic acetylcholine receptor M3 SINGLE PROTEIN AGONIST CHEMBL245

Unichem Links

SureChEMBL SCHEMBL37096
PharmGKB PA448613
Human Metabolome Database HMDB0015154
DrugBank DB01019
PubChem 2370
Mcule MCULE-4959115853
LINCS LSM-5196
Nikkaji J7.089K
BindingDB 39342
EPA CompTox Dashboard DTXSID5048398
DrugCentral 358
Guide to Pharmacology 297
rxnorm URECHOLINE BETHANECHOL CHLORIDE BETHANECHOL
KEGG Ligand C06850
ChEBI 3084